tiprankstipranks

Irit Arbel Insider Profile

4 Followers
Irit Arbel, Director at Brainstorm Cell Therapeutics, holds 155.83K shares in Brainstorm Cell Therapeutics (Ticker: BCLI), holds 0.00 shares in Pluri (Ticker: PLUR). Most recently, Irit Arbel Sold ― shares of Brainstorm Cell Therapeutics on Aug 30, 2019 for an estimated value of 48.80K.
tipranks
Irit Arbel

Irit Arbel
Brainstorm Cell Therapeutics (BCLI)
Director

Ranked #93,611 out of 98,743 Corporate Insiders

Profitable Transactions

0%
0 out of 2 Profitable Transactions

Average Return

-121.60%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$67K
100.00%
0.00%
A breakdown of Irit Arbel's holdings

Insider Roles

Brainstorm Cell Therapeutics
(BCLI)
Director
Pluri
(PLUR)
CEO, Director
Roles that Irit Arbel holds in companies

Most Profitable Insider Trade

Stock:
Brainstorm Cell Therapeutics
(BCLI)
Rating:Informative Buy
Date:Aug 31, 2017 - Aug 31, 2018
Return:-7.00%
The most profitable trade made by Irit Arbel

Irit Arbel's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Brainstorm Cell Therapeutics
Aug 30, 2019
Director
Informative Sell
48.80K
$67.01K
Pluri
CEO, Director
$0.00
List of latest transactions for each holding click on a transaction to see Irit Arbel's performance on stock

Irit Arbel insider profile FAQ

What is the percentage of profitable transactions made by Irit Arbel?
The percentage of profitable transactions made by Irit Arbel is 0%.
    What is the average return per transaction made by Irit Arbel?
    The average return per transaction made by Irit Arbel is -121.60%.
      What stocks does Irit Arbel hold?
      Irit Arbel holds: BCLI, PLUR stocks.
        What was Irit Arbel’s latest transaction?
        Irit Arbel latest transaction was an Informative Sell of $48.80K.
          What was Irit Arbel's most profitable transaction?
          Irit Arbel’s most profitable transaction was an Informative Buy of BCLI stock on August 31, 2017. The return on the trade was -7.00%.
            What is Irit Arbel's role in Brainstorm Cell Therapeutics?
            Irit Arbel's role in Brainstorm Cell Therapeutics is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.